SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-20-317542
Filing Date
2020-12-15
Accepted
2020-12-15 07:34:30
Documents
6
Period of Report
2020-12-14
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d74851d8k.htm 8-K 41424
2 EX-10.1 d74851dex101.htm EX-10.1 123852
3 EX-10.2 d74851dex102.htm EX-10.2 97708
4 EX-99.1 d74851dex991.htm EX-99.1 19575
5 GRAPHIC g74851g1215073009257.jpg GRAPHIC 3266
6 GRAPHIC g74851g1215073009475.jpg GRAPHIC 3574
  Complete submission text file 0001193125-20-317542.txt   293631
Mailing Address 80 GUEST STREET 5TH FLOOR BOSTON MA 02135
Business Address 80 GUEST STREET 5TH FLOOR BOSTON MA 02135 617-225-0096
PROTEOSTASIS THERAPEUTICS, INC. (Filer) CIK: 0001445283 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37695 | Film No.: 201388217
SIC: 2834 Pharmaceutical Preparations